Clinical Trial Update: IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating IACS-6274 with or without Bevacizumab and Paclitaxel in adults with advanced solid tumors; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chondrosarcoma
• Endometrial Cancer
• Head and Neck Squamous Cell Carcinoma
• Melanoma
• Ovarian Cancer
• Ovarian Clear Cell Adenocarcinoma
• Ovarian High Grade Serous Adenocarcinoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• IACS-6274 (IACS-6274)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Endometrial Carcinoma, Advanced Head and Neck Squamous Cell Carcinoma | Phase 1 | Status: RECRUITING